Assisted Reproductive Technology Market Trend Analysis, Latest Revenue Figures, Growth Insights and Forecast to 2030

Assisted Reproductive Technology Market size was estimated at USD 27,489.0 million in 2024 and is projected to reach USD 40,790.46 million in 2031 at a CAGR of 5.8 % during the forecast period 2025-2031.

The assisted reproductive technology (ART) market refers to the range of medical technologies and procedures that assist individuals or couples in achieving pregnancy. These technologies include in vitro fertilization (IVF), intrauterine insemination (IUI), egg/sperm donation, and surrogacy, among others.

Get Free Sample Report: https://www.delvens.com/get-free-sample/assisted-reproductive-technology-market

Impacts USA tariff rates on the Assisted Reproductive Technology Market

​The 2025 U.S. tariffs introduced by President Donald Trump have notably impacted the Assisted Reproductive Technology (ART) market by increasing the cost of essential medical devices and pharmaceuticals. Tariffs on imports from key manufacturing countries have led to higher prices for critical components used in ART procedures, such as incubators, cryopreservation media, and fertility medications.

This escalation in costs has compelled ART providers to either absorb the additional expenses, thereby reducing profit margins, or pass them on to patients, potentially limiting access to fertility treatments. Furthermore, the tariffs have disrupted global supply chains, causing delays in the availability of necessary equipment and medications, which can adversely affect the scheduling and success rates of ART procedures. These challenges have introduced a degree of uncertainty and volatility in the ART market, potentially slowing its growth in the near term.

Delvens Industry Expert's Standpoint on Assisted Reproductive Technology Market

Experts in the Assisted Reproductive Technology Market highlight several key trends driving growth and innovation. The assisted reproductive technology (ART) market involves medical technologies like IVF, IUI, egg/sperm donation, and surrogacy to assist individuals and couples in overcoming infertility challenges.

With a focus on personalized care, the market includes fertility clinics, hospitals, and specialized centers, driven by advancements in genetics, cryopreservation, and AI. Rising infertility rates, delayed childbearing, and increasing awareness are key market drivers, while trends such as egg freezing, fertility preservation, and fertility tourism are contributing to its growth. Technological innovations and broader societal acceptance are shaping the ART market, making reproductive healthcare more accessible and diverse.

The Prominent Players in the Assisted Reproductive Technology Market are

·        Cosmos Biomedical Ltd.

·        Microm U.K. Ltd.

·        CooperSurgical, Inc.

·        FUJIFILM Irvine Scientific

·        Cryolab Ltd.

·        Vitrolife AB

·        European Sperm Bank

·        Bloom IVF Centre

·        Merck KGaA

·        Ferring B.V. and More

For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/assisted-reproductive-technology-market

Analyst view on the impacts of U.S. tariff rates on the Assisted Reproductive Technology Market

·        Despite these challenges, the ART market is anticipated to maintain long-term growth, driven by factors such as increasing infertility rates, advancements in reproductive technologies, and a growing societal acceptance of ART procedures. The demand for ART services remains robust, as individuals and couples continue to seek solutions for infertility.

·        Moreover, the market is expected to adapt by exploring alternative supply chains and investing in domestic manufacturing to mitigate the impact of tariffs. Innovations in ART, including the development of more efficient and cost-effective procedures, are also likely to contribute to market resilience. As the industry navigates these challenges, it is poised to emerge stronger, with a more diversified and robust infrastructure to support sustained growth.

Recent Developments

·        In January 2024, Ivy Fertility teamed up with fertility specialty pharmacy SMP Pharmacy Solutions to improve the patient experience across Ivy’s 13 fertility centers through a joint co-branding initiative. This strategic partnership aimed to enhance service delivery and offer patients comprehensive support, while also benefiting both companies with stronger offerings and increased patient satisfaction.

·        In October 2023, Hamilton Thorne Ltd. acquired Gynetics Medical Products, N.V. and Gynetics Services B.V., a leading manufacturer of innovative, high-quality In-vitro fertilization (IVF) devices. This acquisition broadened Hamilton Thorne's product portfolio, boosting its position and competitive edge in the global IVF market.

Regional Analysis

North America to Dominate the Market

·        North America, particularly the United States, holds a significant share of the global ART market. This dominance is driven by factors such as high infertility rates, increasing maternal age, and advanced healthcare infrastructure.

·        Europe remains a robust market for ART, with countries like Germany, France, and the UK at the forefront. The region benefits from progressive healthcare policies, high success rates in ART procedures, and strong patient demand.

·        The APAC region is experiencing rapid growth in ART adoption, driven by rising infertility rates, delayed marriages, and increasing awareness. Countries like India and China are witnessing a surge in ART procedures, with India emerging as a hub for fertility tourism due to cost-effective treatments.

·        Latin America is witnessing steady growth in ART adoption, influenced by increasing awareness, improving healthcare infrastructure, and supportive government policies. Countries like Brazil and Mexico are leading the region in ART procedures.

·        The MEA region shows a growing interest in ART, particularly in Gulf Cooperation Council (GCC) countries like the UAE and Saudi Arabia, where cultural acceptance and healthcare infrastructure are improving.

Access Full Report: https://www.delvens.com/report/assisted-reproductive-technology-market

In addition to the market data for the Assisted Reproductive Technology Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirements.

Frequently Asked Questions

·        What are the years considered to study Assisted Reproductive Technology Market intelligence report?

·        What is the compound annual growth rate (CAGR) of the Assisted Reproductive Technology Market?

·        Which region holds the largest market share in Assisted Reproductive Technology Market?

·        Which region is the fastest growing in Assisted Reproductive Technology Market?

·        Who are the major players in Assisted Reproductive Technology Market?

More Related Reports:

Assisted Living (AL) Market

Precision Diagnostics and Medicine Market

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

Contact us:

Unit No. 01, 3rd Floor, Plot No. 56, Block B

Sector 2 Noida, Near Noida Sector 15 Metro Station 201301, IN

+44 20 3290 6466

+0120- 4903958

sales@delvens.comv